Pluronic® block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers

AV Kabanov, VY Alakhov - Critical Reviews™ in Therapeutic …, 2002 - dl.begellhouse.com
Pluronicв block copolymers are recognized pharmaceutical excipients listed in the US and
British Pharmacopoeia. The incorporation of drugs into Pluronic micelles results in …

Ethosomes: new prospects in transdermal delivery

B Godin, E Touitou - Critical reviews™ in therapeutic drug …, 2003 - dl.begellhouse.com
Ethosomes are noninvasive delivery carriers that enable drugs to reach the deep skin layers
and/or the systemic circulation. Although ethosomal systems are conceptually sophisticated …

An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy

W Li, X Zhu, X Zhou, X Wang, W Zhai, B Li, J Du… - Journal of Controlled …, 2021 - Elsevier
Blockade of the immune checkpoint PD-1/PD-L1 with monoclonal antibodies demonstrated
unprecedented clinical efficacies in many cancers. But the orally available low molecular …

The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities

JN del Hierro, T Herrera, T Fornari, G Reglero… - Journal of Functional …, 2018 - Elsevier
Saponins are bioactive compounds of increasing interest. The events that take place during
digestion are highly related to their bioactivities, because saponins are poorly absorbed and …

Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties …

D Babadi, S Dadashzadeh, M Osouli… - Journal of controlled …, 2020 - Elsevier
The therapeutic efficacy of orally administered drugs is often restricted by their inherent
limited oral bioavailability. Low water solubility, limited permeability through the intestinal …

Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update

S Liu, X Wen, X Zhang, S Mao - Expert opinion on drug delivery, 2023 - Taylor & Francis
Introduction Biomacromolecules have proven to be an attractive choice for treating diseases
due to their properties of strong specificity, high efficiency, and low toxicity. Besides greatly …

Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids

A Gamboa, N Schüßler, E Soto-Bustamante… - European Journal of …, 2020 - Elsevier
New therapeutics such as antisense oligonucleotides, small interfering RNA and peptide-
drug conjugates are taking great relevance in the pharmaceutical industry due to their …

[HTML][HTML] Development of a smart pH-responsive nano-polymer drug, 2-methoxy-4-vinylphenol conjugate against the intestinal pathogen, Vibrio cholerae

HB Sarveswari, KK Gupta, R Durai, AP Solomon - Scientific Reports, 2023 - nature.com
Vibrio cholerae causes cholera, an acute diarrhoeal disease. The virulence in V. cholerae is
regulated by the quorum-sensing mechanism and response regulator LuxO positively …

Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant

P Bu, S Narayanan, D Dalrymple, X Cheng… - European Journal of …, 2016 - Elsevier
Purpose Caco-2 cells are used extensively for in vitro prediction of intestinal drug
absorption. However, toxicity of excipients and formulations used can artificially increase …

[HTML][HTML] Intestinal permeation enhancers: Lessons learned from studies using an organ culture model

EM Danielsen - Biochimica et Biophysica Acta (BBA)-Biomembranes, 2021 - Elsevier
Permeation enhancers (PEs) are compounds aimed to increase intestinal uptake of oral
drugs with poor bioavailability. This mini-review focuses on results recently obtained with …